These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10631942)

  • 1. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.
    Nakagawa TY; Rudensky AY
    Immunol Rev; 1999 Dec; 172():121-9. PubMed ID: 10631942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal cysteine proteases and antigen presentation.
    Rudensky A; Beers C
    Ernst Schering Res Found Workshop; 2006; (56):81-95. PubMed ID: 16329647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
    Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
    J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.
    Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY
    Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.
    Honey K; Nakagawa T; Peters C; Rudensky A
    J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
    Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY
    J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
    Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
    J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteases involved in MHC class II antigen presentation.
    Villadangos JA; Bryant RA; Deussing J; Driessen C; Lennon-Duménil AM; Riese RJ; Roth W; Saftig P; Shi GP; Chapman HA; Peters C; Ploegh HL
    Immunol Rev; 1999 Dec; 172():109-20. PubMed ID: 10631941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.
    Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteases, processing, and thymic selection.
    Cresswell P
    Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
    [No Abstract]   [Full Text] [Related]  

  • 12. The lysosomal cysteine proteases in MHC class II antigen presentation.
    Hsing LC; Rudensky AY
    Immunol Rev; 2005 Oct; 207():229-41. PubMed ID: 16181340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.
    Riese RJ; Shi GP; Villadangos J; Stetson D; Driessen C; Lennon-Dumenil AM; Chu CL; Naumov Y; Behar SM; Ploegh H; Locksley R; Chapman HA
    Immunity; 2001 Dec; 15(6):909-19. PubMed ID: 11754813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages.
    Lah TT; Hawley M; Rock KL; Goldberg AL
    FEBS Lett; 1995 Apr; 363(1-2):85-9. PubMed ID: 7729559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.
    Nakagawa TY; Brissette WH; Lira PD; Griffiths RJ; Petrushova N; Stock J; McNeish JD; Eastman SE; Howard ED; Clarke SR; Rosloniec EF; Elliott EA; Rudensky AY
    Immunity; 1999 Feb; 10(2):207-17. PubMed ID: 10072073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing.
    Allan ER; Tailor P; Balce DR; Pirzadeh P; McKenna NT; Renaux B; Warren AL; Jirik FR; Yates RM
    J Immunol; 2014 Jun; 192(11):4989-5001. PubMed ID: 24778444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of major histocompatibility complex class II compartments in cortical thymic epithelial cells.
    Arudchelvan Y; Nishimura Y; Tokuda N; Sawada T; Ueyama Y; Fukumoto T
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):798-806. PubMed ID: 12923890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation.
    El-Sukkari D; Wilson NS; Hakansson K; Steptoe RJ; Grubb A; Shortman K; Villadangos JA
    J Immunol; 2003 Nov; 171(10):5003-11. PubMed ID: 14607896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
    Beers C; Honey K; Fink S; Forbush K; Rudensky A
    J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
    Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
    J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.